I once got a 24 day run on the first generation of medtronic sensors. Gen 2 were way way shorter, and this is where my fears lie, as they advertised them as running for twice as long, doubled the price on them and halved the box size because they were FDA approved for 6 days instead of 3 for Gen1. This is a sales angle. Nothing more.
I remember at the time, they were buying back the gen 1 sensors and telling people not to use them on the new pump.
Of course I did as I had a load of them left, and they ran fine… In fact I recall the software was a little more stable, and with the stability of the sensor itself, those gen1’s ran better on the second generation of pump than it did on the first.
My fears, and my unanswered question with this latest revision is, not only are the new sensors/system any good, but did they lock down that ability to re-run them, or start them again if they hit any multitude of problems that this very physical interface can.
It isn’t purely a cost thing for me. If one is running well, why the hell rip it out before it’s done running well, only to replace it with an unknown commodity that may only make it to day 3 before losing the isig?
I’m finding it a little odd to not be able to find out one way or the other.
No one here who has tried one has had reason to ever re-start the sensor?
And, thank you Tim. I’ve been on the edge of jumping ship from medtronic for a while. I like how the pump is integrated with the glucose sensor, but the twitchiness of them is hard to live with.
If anything they should be embracing people like me. People like me could help them understand what about their technology is failing and what users want.
Telling them what they want doesn’t usually end very well.
Are their any waivers to sign before they’ll allow you to purchase this system?
Leaning a closed loop on such a flimsy testing system sounds very much like you’re going to have some legal issues. A lot of them.